Invention Grant
US08926947B2 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
有权
多元醇和聚醚氧化铁络合物作为药理学和/或MRI造影剂
- Patent Title: Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
- Patent Title (中): 多元醇和聚醚氧化铁络合物作为药理学和/或MRI造影剂
-
Application No.: US14301757Application Date: 2014-06-11
-
Publication No.: US08926947B2Publication Date: 2015-01-06
- Inventor: Ernest V. Groman , Kenneth G. Paul , Timothy B. Frigo , Howard Bengele , Jerome M. Lewis
- Applicant: AMAG Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: AMAG Pharmaceuticals, Inc.
- Current Assignee: AMAG Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Goodwin Procter LLP
- Main IPC: A61B5/055
- IPC: A61B5/055 ; A01N43/04 ; A61K31/715

Abstract:
Iron oxide complexes, pharmacological compositions and unit dosage thereof, and methods for their administration, of the type employing an iron oxide complex with a polyol, are disclosed. The pharmacological compositions employ a polysaccharide iron oxide complex, wherein the polysaccharide is a modified polyol such as a carboxyalkylated reduced dextran. The complex is stable to terminal sterilization by autoclaving. The compositions are suitable for parenteral administration to a subject for the treatment of iron deficiencies or as MRI contrast agent. The complex is substantially immunosilent, provide minimal anaphylaxis and undergo minimal dissolution in vivo. The pharmacological compositions of the complex contain minimal free iron which can be quantified by a variety of methods.
Public/Granted literature
- US20140296509A1 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents Public/Granted day:2014-10-02
Information query